Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
UbiA prenyltransferase domain-containing protein-1 (UBIAD1) utilizes geranylgeranyl pyrophosphate (GGpp) to synthesize the vitamin K2 subtype menaquinone-4. The prenyltransferase has emerged as a key regulator of sterol-accelerated, endoplasmic reticulum (ER)-associated degradation (ERAD) of HMG CoA...
Main Authors: | Rania Elsabrouty, Youngah Jo, Seonghwan Hwang, Dong-Jae Jun, Russell A DeBose-Boyd |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-11-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/64688 |
Similar Items
-
The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
by: Marc M Schumacher, et al.
Published: (2015-03-01) -
Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with Ubiad1 deficiency
by: Youngah Jo, et al.
Published: (2020-03-01) -
Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice
by: Youngah Jo, et al.
Published: (2019-02-01) -
Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors
by: Staci L. Haney, et al.
Published: (2017-05-01) -
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target
by: Molly E. Muehlebach, et al.
Published: (2023-01-01)